Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 4;8(2):e001863. doi: 10.1136/bmjdrc-2020-001863

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

The incidence of ESKD in patients with/without hematuria. The survival curves showed that the incidence of ESKD was significantly higher in the hematuria group (log-rank, p<0.0001). The crude HR (95% CI) of hematuria for the incidence of ESKD was 4.11 (2.73 to 6.18). The association remains significant after adjusting for clinically relevant factors. Model 1 was adjusted for sex and age. Model 2 was adjusted for model 1 plus eGFR, proteinuria, systolic blood pressure and BMI. Model 3 was adjusted for model 2 plus pathological findings (glomerular lesion class and IFTA score). BMI, body mass index; eGFR, estimated glomerular filtration rate; ESKD, end-stage kidney disease; IFTA, interstitial fibrosis and tubular atrophy.